David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medicine and Philosophy 20 (1):65-84 (1995)
This article seeks to reframe the ethical discussion of genetic enhancement, which is the use of genetic engineering to supply a characteristic that a parent might want in a child that does not involve the treatment or prevention of disease. I consider whether it is likely that enhancement can be successfully prohibited. If genetic enhancement is feasible, it is likely that there will be demand for it because parents compete to produce able children and nations compete to accumulate human capital in skilled workers. If some parents or nations begin using genetic enhancement, this will change these competitions in ways that increase the incentives for others to use it. Therefore, a ban on genetic enhancement would be unstable, because once the ban was breached by defectors the motivation of others to uphold it would weaken, making the ban liable to collapse. The argument provides a new perspective on slippery slopes to dangerous technology. Keywords: genetic enhancement, slippery slope argumentation CiteULike Connotea Del.icio.us What's this?
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Françoise Baylis & Jason Scott Robert (2004). The Inevitability of Genetic Enhancement Technologies. Bioethics 18 (1):1–26.
Lisa S. Parker (2012). In Sport and Social Justice, Is Genetic Enhancement a Game Changer? Health Care Analysis 20 (4):328-346.
Andy Miah (2012). Genetic Technologies and Sport: The New Ethical Issue. Journal of the Philosophy of Sport 28 (1):32-52.
Darryl Macer (2012). Ethical Consequences of the Positive Views of Enhancement in Asia. Health Care Analysis 20 (4):385-397.
Mark J. Cherry (2015). Medicine, Morality, and Mortality: The Challenges of Moral Diversity. Journal of Medicine and Philosophy 40 (5):473-483.
Similar books and articles
Ashkan Atry, Mats G. Hansson & Ulrik Kihlbom (2011). Gene Doping and the Responsibility of Bioethicists. Sport, Ethics and Philosophy 5 (2):149 - 160.
Terrance Mcconnell (2011). Genetic Enhancement and Moral Attitudes Toward the Given. Journal of Applied Philosophy 28 (4):369-380.
W. French Anderson (1989). Human Gene Therapy: Why Draw a Line? Journal of Medicine and Philosophy 14 (6):681-693.
Larry A. Herzberg (2007). Genetic Enhancement and Parental Obligation. Philosophy in the Contemporary World 14 (2):98-111.
Matthew DeCamp & Allen Buchanan (2007). Pt. VI. Genetics and Enhancement. Population Genetic Research and Screening: Conceptual and Ethical Issues / Eric Juengst ; Enhancement / Thomas Murray ; Genetic Interventions and the Ethics of Enhancement of Human Beings / Julian Savulescu ; Pharmacogenomics: Ethical and Regulatory Issues. [REVIEW] In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press
T. Mcconnell (2010). Genetic Enhancement, Human Nature, and Rights. Journal of Medicine and Philosophy 35 (4):415-428.
David Resnik (1994). Debunking the Slippery Slope Argument Against Human Germ-Line Gene Therapy. Journal of Medicine and Philosophy 19 (1):23-40.
Michael Fuchs (2010). Reshaping Human Intelligence: The Debate About Genetic Enhancement of Cognitive Functions. Human Reproduction and Genetic Ethics 16 (2):165-181.
Maxwell J. Mehlman (2005). Genetic Enhancement: Plan Now to Act Later. Kennedy Institute of Ethics Journal 15 (1):77-82.
Jason Borenstein (2009). The Wisdom of Caution: Genetic Enhancement and Future Children. Science and Engineering Ethics 15 (4):517-530.
Added to index2010-08-24
Total downloads37 ( #96,547 of 1,781,467 )
Recent downloads (6 months)6 ( #108,213 of 1,781,467 )
How can I increase my downloads?